SG Americas Securities LLC Has $4.75 Million Stock Position in Integer Holdings Corporation $ITGR

SG Americas Securities LLC grew its position in Integer Holdings Corporation (NYSE:ITGR) by 127.3% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 45,951 shares of the medical equipment provider’s stock after purchasing an additional 25,732 shares during the period. SG Americas Securities LLC’s holdings in Integer were worth $4,748,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in Integer by 4.0% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 21,515 shares of the medical equipment provider’s stock worth $2,539,000 after buying an additional 837 shares during the last quarter. Millennium Management LLC increased its stake in shares of Integer by 2,408.8% during the 1st quarter. Millennium Management LLC now owns 123,132 shares of the medical equipment provider’s stock worth $14,531,000 after purchasing an additional 118,224 shares during the last quarter. Jones Financial Companies Lllp raised its holdings in shares of Integer by 79,888.9% during the 1st quarter. Jones Financial Companies Lllp now owns 7,199 shares of the medical equipment provider’s stock valued at $850,000 after purchasing an additional 7,190 shares in the last quarter. United Services Automobile Association acquired a new stake in shares of Integer in the 1st quarter valued at $258,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in Integer by 4.7% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 109,316 shares of the medical equipment provider’s stock worth $12,900,000 after purchasing an additional 4,873 shares in the last quarter. Institutional investors own 99.29% of the company’s stock.

More Integer News

Here are the key news stories impacting Integer this week:

• Neutral Sentiment: Lead-plaintiff deadline set for February 9, 2026 — multiple notices remind investors who bought ITGR between July 25, 2024 and October 22, 2025 to file if they want to seek lead-plaintiff status. Berger Montague investor reminder
• Negative Sentiment: Multiple law firms (Levi & Korsinsky, Berger Montague, Schall, BFA, Gross, Glancy, Bernstein Liebhard, Bronstein, ClaimsFiler and others) have publicized a securities class action against Integer alleging securities-fraud-related claims tied to a prior share-price drop. These coordinated notices increase the probability of consolidated litigation, media scrutiny and potential settlement exposure. Levi & Korsinsky notice
• Negative Sentiment: Allegations include violations of §§10(b) and 20(a) and Rule 10b-5; class period and alleged misstatements are specified in several firm filings — this frames the legal theory and the types of damages plaintiffs will seek, which could raise defense costs and settlement risk. Schall Law Firm notice
• Negative Sentiment: Firms emphasize prior “significant stock drop” and encourage loss claims — if plaintiffs demonstrate class-wide losses, settlement pressures increase; the timing of filings, discovery and potential injunctions could add near-term volatility. PR Newswire Levi & Korsinsky

Integer Price Performance

Shares of NYSE:ITGR opened at $84.39 on Friday. The company has a market cap of $2.96 billion, a price-to-earnings ratio of 35.31, a PEG ratio of 0.77 and a beta of 0.78. The business has a 50 day moving average price of $73.30 and a 200 day moving average price of $94.38. The company has a quick ratio of 2.45, a current ratio of 3.71 and a debt-to-equity ratio of 0.70. Integer Holdings Corporation has a twelve month low of $62.00 and a twelve month high of $146.36.

Integer (NYSE:ITGR) last issued its quarterly earnings results on Thursday, October 23rd. The medical equipment provider reported $1.79 EPS for the quarter, topping analysts’ consensus estimates of $1.68 by $0.11. Integer had a return on equity of 12.84% and a net margin of 4.75%.During the same quarter last year, the firm earned $1.43 earnings per share. The company’s quarterly revenue was up 8.4% compared to the same quarter last year. Integer has set its FY 2025 guidance at 6.290-6.430 EPS. Research analysts predict that Integer Holdings Corporation will post 6.01 earnings per share for the current year.

Integer announced that its Board of Directors has approved a share buyback program on Tuesday, November 4th that permits the company to repurchase $200.00 million in shares. This repurchase authorization permits the medical equipment provider to buy up to 8.3% of its stock through open market purchases. Stock repurchase programs are generally a sign that the company’s management believes its shares are undervalued.

Insider Activity at Integer

In related news, EVP Diron Smith acquired 1,116 shares of the company’s stock in a transaction dated Friday, November 7th. The shares were bought at an average price of $67.19 per share, for a total transaction of $74,984.04. Following the acquisition, the executive vice president owned 7,698 shares in the company, valued at $517,228.62. This trade represents a 16.96% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Payman Khales bought 3,127 shares of Integer stock in a transaction that occurred on Thursday, October 30th. The stock was bought at an average price of $64.94 per share, with a total value of $203,067.38. Following the purchase, the chief executive officer owned 22,865 shares of the company’s stock, valued at $1,484,853.10. This trade represents a 15.84% increase in their position. The SEC filing for this purchase provides additional information. Insiders have bought 5,843 shares of company stock valued at $384,771 in the last 90 days. 2.16% of the stock is owned by company insiders.

Analysts Set New Price Targets

ITGR has been the topic of several recent research reports. Benchmark restated a “hold” rating on shares of Integer in a report on Friday, October 24th. KeyCorp lowered their price objective on Integer from $145.00 to $133.00 and set an “overweight” rating on the stock in a report on Tuesday, October 21st. Raymond James Financial restated an “outperform” rating and issued a $95.00 target price (down from $143.00) on shares of Integer in a report on Friday, October 24th. Piper Sandler lowered their price target on Integer from $155.00 to $82.00 and set an “overweight” rating on the stock in a report on Friday, October 24th. Finally, Argus lowered shares of Integer from a “buy” rating to a “hold” rating in a research report on Friday, October 24th. Four equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $98.38.

Integer Profile

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.